Novel approaches to a sustainable industrial «white» biotechnology

ScanBalt Forum 2010, September 22-24, 2010, Tallin, Estonia

BIOCATALYSIS2021-Cluster-Partners as Speakers

The forum subtitled as “Healthy Future” will focus on the variety of issues from life style and food to health related technologies and services as well as industrial biotechnology (with BIOCATALYSIS2021-Partners). All these issues are targeting to longer and better life, whether by getting more efficient and effective health services or improving our environment. The forum is organised jointly by ScanBalt, Enterprise Estonia, Estonian Genome Foundation and Estonian Biotech Association. Red more and register following the link: ScanBalt Forum 2010.

biocat2010

International Congress on Biocatalysis, August 29 until September 2, in Hamburg

On behalf of the Scientific and Organizing Committees, Professor Garabed Antranikian invites scientists from all over the world to the 5th International Congress on Biocatalysis - biocat2010 - to be held from August 29 until September 2 at the Hamburg University of Technology.


analytica 2010|March 23-26|Meet our Experts in Munich

Focus on Industrial Biotechnology on March 25

In the Forum Biotech on Thursday 25th of March, the BMBF-Clusters BioIndustry 2021 will present the potential of their scientific work in Munich. Speaker of BIOCATALYSIS2021 will be Professor Garabed Antranikian, Vice President of the Hamburg University of Technology, and Coordinator of the Cluster with his lecture: "From lab to process: Novel approaches to a new generation of biocatalysts and their possible application in industry." Read More

EMBL and BIOCATALYSIS2021

EMBL@Petra-3 | Competence-workshop focusing on applications of structural biology in academic research

On Tuesday 23rd of February, EMBL Hamburg, together with the BIOCATALYSIS2021, hosted a workshop focusing on applications of structural biology in academic research. Aboout sixty participants from science and industry attended the evening event aimed at reinforcing existing links between EMBL Hamburg and industry partners, and encouraging new collaborations and projects within BIOCATALYSIS2021. Read More


Live Webinar on February 18, 2010 - Guest Presenter is Prof. Dr. Andreas Liese from Hamburg University of Technology and BIOCATALYSIS2021

"Conversion Prediction of an Enzymatic Esterification"

Nowadays, fatty acid esters are irreplaceable components in modern cosmetics and skin care products. The biocatalytic production of these esters gives broad advantages compared to the convenient chemically catalyzed processes in view of decreasing waste production and levels of undesired by products.


Personalia - DIREVO

DIREVO Industrial Biotechnology appoints Dr. Jörg Riesmeier as Chief Operating Officer

On January 18, 2010, DIREVO announced the appointment of Dr. Joerg Riesmeier as Managing Director and Chief Operating Officer (COO) with immediate effect.


September 20-24, 2009, Groningen, The Netherlands

Conference Enzyme Engineering 2009

The topics of Enzyme Engineering 2009 are of high relevance for industrial biocatalysis as well as for important issues of the emerging Bio-Based Economy, such as the development and use of enzymes for sustainable production of biofuels and biomaterials. Among the Invited Speakers is BIOCATALYSIS-Partner Professor Wolfgang Streit, University of Hamburg. Lecture: "Finding Robust Biocatalysts in Soil Metagenomes".
More Information: Website ENZYME ENGINEERING XX.

Call for Papers - Deadline August 30, 2009

BioSys International Conference for Biosystems Analysis and Engineering, October 15-17, 2009 at Hamburg University of Technology

Conference Chair BIOCATALYSIS2021-Partner Professor An-Ping Zeng: "Both biology and engineering are entering new eras owing to rapid advances in enabling technologies such as genome sequencing, functional genomics, computation, microfluidics and nanotechnology.


World Congress on Industrial Biotechnology and Bioprocessing from July 19-22 in Montreal, Canada

German Alliance for Industrial Biotechnology Debuts in Montreal

Dr. Ralf Grote, Senior Manager of our Cluster BIOCATALYSIS2021, presented the potential of the German clusters of industrial biotechnology at this year’s congress. In addition, Manfred Kircher, Chairman of the Board of Cluster Industrial Biotechnology 2021 e.V. (CLIB2021) presented international business solutions based on industrial biotechnology. Dr. Markus Wolperdinger, Consultant for InfraLeuna GmbH, highlighted biorefinery as a case study, specifically the integration of Page bio-based processes and renewable resources into an established fossil-based refinery site. More Information: Websites World Congress on Industrial Biotechnology and Bioprocessing and Germany Trade & Invest.



"Discover Germany's Competence in Industrial Biotechnology"

"BIO International Convention in Atlanta/Georgia" May 18 - 21, 2009

You will meet several BIOCATALYSIS-Partners in Atlanta. The winner of the BMBF-Cluster Competition BioIndustry 2021: BIOCATALYSIS2021, BIOPRO, CLIB2021 und CIB Frankfurtwill be presented in German Pavilion, Booth 2741.
Website Bio International Convention und German Pavilion



Wiley InterScience: New Journal - Coming soon

ChemCatChem - Heterogeneous, Homogeneous, and Biocatalysis

ChemCatChem is aimed to become a top-ranking journal for the entire catalysis community. The journal will provide primary research papers and critical secondary information on heterogeneous and homogeneous catalysis as well as biocatalysis, and will strengthen cross-communication within and between these communities.



News Archive

You are looking for more News?

Euro Biotech News

Six GMO maize events sail through commission

Brussels - The European Commission approved the import of six types of genetically modified (GM) maize - after the...

£50m government fund for access to new cancer drugs

Britain's coalition government plans to boost the sale and use of innovative cancer drugs in the British Health system....

Cerenis SA collects EUR 50m from French government and private investors

Cerenis Therapeutics SA raised EUR40m in a Series C financing round from the French Government and existing investors....

Sanofi in pursuit of Genzyme

Paris-based drug company Sanofi-Aventis appears to be considering spending more than US-$20 billion for Genzyme Corp.,...

International Stem Cell Corporation sets up $10m European subsidiary

The International Stem Cell Corporation wants to set up shop in Europe. The California-based biotechnology company...